Sebastián Bermúdez Puga

Mr. Sebastián Bermúdez Puga

University of São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
Sebastián Bermúdez PugaSebastián Bermúdez Puga
Sebastián Bermúdez Puga
MDMeriellen Dias
Meriellen Dias
TOTaciana Freire de Oliveira
Taciana Freire de Oliveira
CMCarlos Miguel Nóbrega Mendonça
Carlos Miguel Nóbrega Mendonça
SASonia Regina Yokomizo de Almeida
Sonia Regina Yokomizo de Almeida
RORicardo Oliveira
Ricardo Oliveira
Salmonella genus is a leading cause of food-borne infections with strong public health impact and economic ramifications. The development of antimicrobial resistance added complexity to this scenario and turned the antibiotic drug discovery into a highly important challenge. The screening of peptides has served as a successful discovery platform to design new antibiotic candidates. Motivated by this, the antimicrobial and cytotoxic properties of three cruzioseptins against Salmonella Typhimurium and RAW 264.7 murine macrophage cells, respectively, were investigated. [K4K15]CZS-1 was the most potent antimicrobial peptide identified in the screening step with a minimum inhibitory concentration (MIC) of 16 μg/mL (7.26 μM) and moderate cytotoxicity. From a structural point of view, in vitro and in silico techniques evidenced that [K4K15]CZS-1 is a α-helical cationic antimicrobial peptide. In order to capture mechanistic details and fully decipher their antibacterial action, we adopted a multidimensional approach, including spectroscopy, electron microscopy and omics analysis. In general lines, [K4K15]CZS-1 caused membrane damage, intracellular alterations in Salmonella and modulated metabolic pathways, such as the tricarboxylic acid (TCA) cycle, fatty acid biosynthesis, and lipid metabolism. Overall, these findings provide deeper insights into the antibacterial properties and multidimensional mode of action of [K4K15]CZS-1 against Salmonella Typhimurium. In summary, this study represents a first step toward the screening of membrane-acting and intracellular-targeting peptides as potential bio-preservatives to prevent foodborne outbreaks caused by Salmonella.

26 February 2022 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
FVFernando Valdivieso-Rivera
Fernando Valdivieso-Rivera
Sebastián Bermúdez PugaSebastián Bermúdez Puga
Sebastián Bermúdez Puga
Carolina Proaño-BolañosCarolina Proaño-Bolaños
Carolina Proaño-Bolaños
José Rafael de AlmeidaJosé Rafael de Almeida
José Rafael de Almeida

23 February 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
TOTaciana Freire Oliveira
Taciana Freire Oliveira
TKTaís Mayumi Kuniyoshi
Taís Mayumi Kuniyoshi
Elionio Galvão FrotaElionio Galvão Frota
Elionio Galvão Frota
Sebastián Bermúdez PugaSebastián Bermúdez Puga
Sebastián Bermúdez Puga
LSLetícia Naomy Sakaue
Letícia Naomy Sakaue
RORicardo Oliveira
Ricardo Oliveira
Listeria monocytogenes is a foodborne pathogen that contaminates food-processing environments and persists within biofilms on equipment, thus reaching final products by cross-contamination. With the growing demand for clean-label products, the search for natural antimicrobials as biopreservants, such as bacteriocins, has shown promising potential. In this context, this study aimed to evaluate the anti-listerial action of bacteriocins produced by Enterococcus lactis LBM BT2 in an alternative medium containing sugarcane molasses (SCM). Molecular analyses were carried out to characterize the strain, including the presence of bacteriocin-related genes. In the kinetic study on SCM medium E. lactis, LBM BT2 showed biomass and bacteriocin productions similar to those observed on a sucrose-based medium (control), highlighting the potential of the sugarcane molasses as a low-cost substrate. Stability tests revealed that the molecule remained active in wide ranges of pH (4–10) and temperature (60–100 °C). Furthermore, the proteolytic treatment reduced the biomolecule’s antimicrobial activity, highlighting its proteinaceous nature. After primary purification by salting out and tangential flow filtration, the bacteriocin-like inhibitory substance (BLIS) showed bacteriostatic activity on suspended L. monocytogenes cells and against biofilm formation at a concentration of 0.625 mg/mL. These results demonstrate the potential of the produced BLIS as a biopreservative in the food industry.

6 January 2023 in Amino Acids
Verified
Journal Article
Closed access
PDF file
Sebastián Bermúdez PugaSebastián Bermúdez Puga
Sebastián Bermúdez Puga
GMGiovanna Morán-Marcillo
Giovanna Morán-Marcillo
NMNina Espinosa de Los Monteros-Silva
Nina Espinosa de Los Monteros-Silva
RNRenato E. Naranjo
Renato E. Naranjo
FTFernanda Toscano
Fernanda Toscano
Carolina Proaño-BolañosCarolina Proaño-Bolaños
Carolina Proaño-Bolaños

21 November 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
SBStefanny Bonilla-Jiménez
Stefanny Bonilla-Jiménez
NMNina Q. Espinosa de los Monteros-Silva
Nina Q. Espinosa de los Monteros-Silva
GMGiovanna Moran
Giovanna Moran
Sebastián Bermúdez PugaSebastián Bermúdez Puga
Sebastián Bermúdez Puga
ATAndrea Terán-Valdez
Andrea Terán-Valdez
Carolina Proaño-BolañosCarolina Proaño-Bolaños
Carolina Proaño-Bolaños
Background/Objectives: The increasing antimicrobial resistance is a current human health threat, which has stimulated research on new biologically active molecules against infections caused by microorganisms resistant to conventional therapies. Antimicrobial peptides (AMPs) from amphibian skin secretions have generated great interest in tackling this problem due to their antibacterial, antifungal, antiprotozoal, wound-healing, and even anticancer properties. In Ecuador, there are still unexplored endemic amphibian species as a source of new AMPs, such as Callimedusa ecuatoriana. In this study, we report a novel peptide derived from the skin secretion of Callimedusa ecuatoriana identified by molecular cloning of the mRNA precursor. The functional analysis demonstrated that it lacks antimicrobial activity due to its alpha-helix kink structure. Methods: Inspired by the native structure of PTR-CE1, we designed and synthesized two analogs (PTR-CE1a and PTR-CE1b) to adopt a complete α-helix secondary structure, a conformation often associated with antimicrobial activity. In silico tools were used to predict the peptide activity, which was confirmed by experimental findings. Results: Both analogs displayed higher activity than the native peptide, even against the ampicillin-resistant bacterial strain. While PTR-CE1b showed Minimum Inhibitory Concentration (MIC) values of 26.62–212.99 μM and 24.36% of hemolytic activity at 26.62 μM, PTR-CE1a displayed a more potent broad-spectrum activity against all the microorganisms, with MIC values of 3.02–12.06 μM and hemolytic activity of 7.5% at 3.02 μM. Conclusions: This study demonstrates the importance of the α-helix structure for antimicrobial activity in C. ecuatoriana PTR-CE1 analogs and highlights the potential of unexplored biological and molecular diversity in endemic species of Ecuador to provide novel templates for peptide design.

22 April 2020 in Ecuador es Calidad
Verified
Journal Article
Open access
PDF file
Sebastián Bermúdez PugaSebastián Bermúdez Puga
Sebastián Bermúdez Puga
FRFernando Valdivieso Rivera
Fernando Valdivieso Rivera
CBCarolina Proaño Bolaños
Carolina Proaño Bolaños
Pacientes con fibrosis quística (FQ) presentan alteraciones en la superficie de las vías respiratorias del pulmón, donde se producen secreciones mucosas densas difíciles de eliminar y altas concentraciones de sales (NaCl). Esto genera un ambiente propicio para la colonización y el crecimiento de patógenos como Staphylococcus aureus. Al ser un entorno hiperosmótico, provoca un incremento en la formación de biopelículas, lo que conlleva a una infección crónica persistente e incremento de la resistencia antibiótica. [1] Ante lo mencionado y la falta de nuevos antibióticos, surgen nuevas alternativas para combatir los organismos multirresistentes, entre ellas, los péptidos antimicrobianos (AMPs). Los AMPs exhiben una potente actividad contra microrganismos resistentes en los ensayos in vitro. Sin embargo, bajo condiciones fisiológicas, su actividad antimicrobial se reduce hasta 4 veces, lo que no permite su aplicación clínica. [1, 2]